In recent years a great deal of evidence6 has accumulated which indicates a close relation between the liberation of histamine and various allergic and anaphylactic reactions. We have therefore been employing histamine as a non-specific "desensitizing" agent in most of our allergic patients during the past few years. Our results with this form of th,erapy are discussed elsewhere.7 8
In recent years a great deal of evidence6 has accumulated which indicates a close relation between the liberation of histamine and various allergic and anaphylactic reactions. We have therefore been employing histamine as a non-specific "desensitizing" agent in most of our allergic patients during the past few years. Our results with this form of th,erapy are discussed elsewhere. 7 8 In a series of investigations, Code' 2, 3 '4' 5 has shown that the principal source of the histamine in the blood stream is probably the circulating eosinophils. It is well known that most allergic patients show an eosinophilia,9 although this is not constant and does not appear to be related in any obvious manner with the severity of the symptoms. The relationship between eosinophils and allergic diseases is not clear. As Peshkin and Messer"' have stated:
"Eosinophilia is met with in a variety of conditions, but it is generally agreed that the eosinophil is in some way bound up with the allergic syndrome."
In view of the apparent interrelation between allergic diseases, the release of histamine, and the circulating eosinophils, it was decided to investigate the effect of a course of histamine injections on the percentage of the eosinophils in the blood of a group of allergic patients. A review of the literature shows that many substances, injected into man and animals, have produced an eosinophilia. An extensive bibliography of this subject is given by Peshkin and Messer,1 who summarize their work and that of others as follows: "Eosinophilia in animals has been brought about experimentally by the injection of a variety of protein substances. Moreover, it has been shown that eosinophilia follows repeated injections of large doses of an antigenic substance-specific or non-specific. The response of the eosinophil cells to various antigenic substances in the animal is in marked contrast to the lack of uniformity of response in man. The stimulating influence of antigenic substances on the eosinophil cells in man seems to be bound up with the particular antigen employed rather than the dose or the number of injections administered."
The effect of histamine injections on the white blood cells of man and animals has been reported by a few investigators. This work has been summarized by Moon, Lieber, and Kennedy."0 All the experiments consisted of noting the variations in the white blood cell count after a single injection of histamine. Although the various investigators disagree concerning the exact changes, all are in essential agreement that the counts almost always return to approximately the initial level within 24 hours. It is probable that the fluctuations depend on temporary vascular changes with redistribution of the white cells. A problem which seems of considerably more theoretical interest in the study of allergic diseases is what changes, if any, occur in the level of circulating eosinophils as a result of a long series of injections of histamine.
Experimental
The patients included in this study were all hay-fever sufferers. A few of them also had asthma or vasomotor rhinitis, but the large majority had no clinical manifestations of allergy other than pollenosis. They were all being given pre-seasonal treatment with gradually increasing doses of histamine phosphate (1.0 cc.-1.0mg.) subcutaneously at intervals of from 2 to 7 days. The initial injection was in most instances 1.0 gamma, although it varied from 0.05 to 1.0 gamma. The increase in dosage in subsequent injections was approximately 50 to 100 per cent, with a maximum dosage of from 120 to 200 gamma in the majority of patients. The number of injections and the total dose for each patient are shown in the table. Treatment was over an average period of 11.5 weeks. Only those patients, 22 in number, who came regularly and who received an adequate amount of histamine are included in this study.
Blood smears were taken from each individual just before the first injection and again two to four days after an injection given shortly before the onset of the hay-fever season. Thus, the count was not influenced in any case by the presence of hay-fever. The smears were stained with MacNeal's tetrachrome stain, which was left on the slide for 2 to 3 minutes, followed by tap Discussion In the 22 cases studied, the eosinophils prior to starting the histamine injections averaged 3.44 per cent and at the end of the course of injections averaged 3.70 per cent. It is apparent that in this series of patients histamine exerted no appreciable effect on the level of blood eosinophils. This was confirmed by an analysis which showed that the difference in the two averages is not statistically significant. Although the number of patients studied is small, the results are sufficiently definite to claim that injections of histamine given over a period of many weeks do not consistently cause an appreciable change in the percentage of circulating eosinophils. Since there seems to be some interrelationship between allergic conditions, histamine, and blood eosinophils, as mentioned earlier, a definite change in the eosinophil percentage under the conditions of the experiment might have been of some theoretical interest. Since there was no significant change, it would appear that the therapeutic value of histamine injections in allergic diseases is not the result of a change in the percentage of circulating eosinophils.
Summary
Twenty-two patients subject to hay-fever received a long series of histamine injections without producing a significant change in the average level of circulating eosinophils.
